The Local Organizing Committee and the International Scientific Committee of WC11 are working hard to present an innovative and interesting program to you in Maastricht. The program will be centered around four themes ‘Safety’, ‘Innovative technologies’, ‘Ethics, Welfare and Regulation’ and ‘Disease’.

Scientific Program

The Scientific Program Committee has tentatively accepted 81 sessions for presentation during the 11th World Congress on Alternatives and Animal Use in the Life Sciences. More details on these sessions and others, still under review, as well as the official schedule, will be available at a later date.


  1. Safety
  2. Innovative Technologies
  3. Ethics, Welfare and Regulation
  4. Disease

Special focus: Education and Training


Click here for the program at a glance.

Confirmed plenary keynote lectures


  • Prof. Annelien Bredenoord: Ethics of innovative technologies
  • Dr. Jason Ekert: Novel 3R technologies in early drug discovery
  • Dr. Don Ingber: Novel non‐animal technologies in disease mechanisms (microphysiological systems, organoids and Organ‐on‐a‐Chip)
  • Prof. Dr. Malcolm MacLeod: Data quality in translational research
  • Dr. Russel Thomas: Computational systems toxicology-real world evidence

* more will follow

Click here to read more about the plenary keynote speakers.

Symposium sessions, workshops and round tables

Please find below a list of provisional titles for sessions accepted by the Scientific Program Committee, including the name of the submitter.


  • Symposium: Flexible, efficient and performance-driven in-house method validation responding to current regulatory challenges for identifying human thyroid disruptors – Submitted by: Sandra Coecke, European Commission Joint Research Centre
  • Symposium: Application of an in vitro testing battery for developmental neurotoxicity assessment in a regulatory context – Submitted by: Anna Bal-Price, European Commission Joint Research Centre
  • Workshop: Validation redefined: needs and opportunities for the validation of (r)evolutionary non-animal approaches for chemical safety assessment – Submitted by: Janine Ezendam, National Institute for Public Health and the Environment
  • Symposium: AOPs, MOAs, and KCs – Mutually Informative, Not Mutually Exclusive – Submitted by: Patience Browne, OECD
  • Workshop: Modern, Mechanistic Approaches to Cancer Risk Assessment – Submitted by: Gina Hilton, PETA International Science Consortium, Ltd.
  • Symposium: Methods to enhance biotransformation capability for in vitro high throughput screening assays – Submitted by: Menghang Xia, SOT/National Center for Advancing Translational Sciences
  • Symposium: New Approach Methods in AgroChemical Development and Regulatory Decisions – Submitted by: Douglas Wolf, Syngenta Crop Protection
  • Symposium: Integrated Approach to Testing and Assessment: Occam’s razor for New Approach Methodologies in 21st Century Human Health Decision-Making – Submitted by: Jason Lambert, U.S. Environmental Protection Agency
  • Symposium: Decision making in non-animal cosmetic safety assessment – Submitted by: Paul Russell, Unilever
  • Symposium: Computational Synthesis and Integration for Systems Toxicology in the Animal-free Zone – Submitted by: Thomas Knudsen, US EPA
  • Symposium: Why and how to model the distribution of chemicals in in vitro assays for quantitative in vitro-in vivo extrapolation – Submitted by: Nynke Kramer, Institute for Risk Assessment Sciences
  • Symposium: EU-ToxRisk Guidance for New Approach Methods (NAM)-supported Read-Across Approaches – Submitted by: Bob van de Water, Leiden University/ EU-ToxRisk
  • Symposium: Alternative and predictive methods for environmental risk assessment of cosmetics – Submitted by: Véronique Poulsen, L’Oréal
  • Workshop: Lessons learned from applying non-animal skin sensitisation methods: from hazard assessment to next generation risk assessment – Submitted by: Janine Ezendam, National Institute for Public Health and the Environment
  • Workshop: Lessons Learned and Practical Considerations for the Use of In Vitro Exposure Systems to Assess Respiratory Toxicity – Submitted by: Amy Clippinger, PETA International Science Consortium Ltd.
  • Symposium: Building confidence in NexGen Risk Assessment – Submitted by: Carl Westmoreland, Unilever
  • Other: A walk through 10 years of CAAT-Europe’s highlights – Submitted by: Marcel Leist, CAAT-Europe/ University of Konstanz
  • Symposium: Promoting the use of 3Rs through partnership: EPAA – Submitted by: Zvonimir Zvonar, European Partnership for Alternative Approaches to Animal testing (EPAA)
  • Round Table: Asia: A place ripe for the development of 21st century science – Submitted by: Alokparna Sengupta, Humane Society International India
  • Symposium: Challenges of Non-Animal Approaches for Food Safety & Nutrition in the 21st Century: From Inception to Application – Submitted by: Lucie Geurts, ILSI Europe
  • Symposium: The in3 project: An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment – Submitted by: Paul Jennings, Vrije Universiteit Amsterdam

Innovative Technologies

  • Workshop: Can non-animal models identify environmental endocrine disruptors? –Submitted by: Nina Hallmark, Bayer AG
  • Workshop: “Innovative approaches for CNS research – from brain organoids to new single cell culture methods” – Submitted by: Jeffrey Bajramovic, Biomedical Primate Research Centre
  • Workshop: Diving into the scientific knowledge big data looking for alternatives – Submitted by: Marco Straccia, FRESCI
  • Symposium: Novel cell-based technologies for predicting drug-induced liver injury – Submitted by: Catherine Verfaillie, Katholieke Universiteit Leuven
  • Symposium: Emerging 3D organoid technology toward animal alternative testing – Submitted by: Yasu Kanda, National Institute of Health Sciences
  • Symposium: The Role of Artificial Intelligence in Safety and Toxicity Assessment – Submitted by: Weida Tong, NCTR/FDA
  • Symposium: Innovative technologies integrating standardised regulatory test methods: challenges and perspectives – Submitted by: Anne Gourmelon, OECD
  • Dynamic session: A Virtual Human Platform for Safety Assessment – Submitted by: Cyrille Krul, University of Applied Sciences Utrecht
  • Workshop: Using the Sematic Web for Rapid Integration of Publicly Available Biological Information – Submitted by: Holly mortensen, US EPA
  • Symposium: Scientific highlights in emulating human biology on chips – Submitted by: Uwe Marx, Tissuse
  • Symposium: Personalized medicine through human organoid models – Submitted by: Christine Mummery, Leiden University Medical Center
  • Symposium: Translational success of industrial adoption of organ-on-a-chip platforms – Submitted by: Adrian Roth, Hoffman La Roche
  • Symposium: Human Organs-on-Chips: Advancing Regulatory Science through Innovation – Submitted by: Suzanne Fitzpatrick, US Food and Drug Administration
  • Workshop: Alternatives to Fetal Bovine Serum (FBS) – Submitted by: Tilo Weber, German Animal Welfare Federation / Animal Welfare Academy
  • Workshop: Use of New approach methodologies –NAMs- to derive Point(s) of departure; opportunities and limitations – Submitted by: Gladys Ouedraogo, L’Oreal
  • Dynamic session: Organoid technology for infectious diseases: from innovation to established models – Submitted by: Dasja Pajkrt, Academic Medical Center
  • Workshop: Harnessing the power of data to improve systemic toxicity prediction: multisectorial perspectives – Submitted by: Stephane Dhalluin, L’Oreal

Ethics, Welfare and Regulation

  • Symposium: Wildlife research and the 3Rs – Submitted by: Miriam Zemanova, Centre for Compassionate Conservation, University of Technology Sydney
  • Symposium: Sharing organs and tissues to reduce the lab animal usage – Current update on existing biobanks and sharing platforms – Submitted by: Annemarie Lang, Charité-Universitätsmedizin Berlin
  • Symposium: Implementing the 3Rs in Genetically Altered animals – Submitted by: David Anderson, Commission
  • Symposium: Refinement of pain & stress assessment to enhance animal welfare in rodents – Submitted by: Nuno Henrique Franco, i3S, University of Porto
  • Symposium: Focus on Severe Suffering – Submitted by: Elliot Lilley, RSPCA
  • Round Table: “How to avoid polarization in dealing with uncertainties in public, scientific and regulatory debate” – Submitted by: Jeffrey Bajramovic, TRAIN
  • Workshop: Open Science and Transparency in Animal-Based Research – Submitted by: Paulin Jirkof, University Zurich / Laboratory Animals (Editor)
  • Dynamic session: Systematic Review, Machine Learning and Data-Driven Alternatives – Submitted by: Brett Lidbury, The Australian National University
  • Workshop: Barriers of Refinement Use in Practice – Submitted by: Cathy Schuppli, University of British Columbia
  • Workshop: Establishing a European Network of 3Rs Centers and 3Rs-Societies – Submitted by: Horst Spielmann, Freie Universität Berlin
  • Workshop: Animal Experimentation: Working Towards a Paradigm Change – Submitted by: Kathrin Herrmann, Johns Hopkins Bloomberg School of Public Health
  • Workshop: Culture of Care – a culture driven, pro-active approach towards improving standards – Submitted by: Thomas Bertelsen, Novo Nordisk
  • Workshop: The Animal Welfare Body – how are we doing? – Submitted by: Penny Hawkins, RSPCA Research Animals Department
  • Round Table: Implementing openness: promoting transparency around animal research across regions – Submitted by: Bella Williams, Understanding Animal Research
  • Workshop: Continuous training of Animal Welfare Body members – Submitted by: Cindy Kunne, Dutch AWB platform
  • Round Table: Industry and public sector partnerships in education to foster the implementation of alternative methods – Submitted by: Christian Pellevoisin, EPISKIN
  • Symposium: Advancing 3R education and training under a European Parliament Pilot Project – overview session – Submitted by: Susanna Louhimies, European Commission
  • Round Table: “Proof in animals”: Has journal editorial policy fallen behind advances in human-based approaches? – Submitted by: Marcia Triunfol, Humane Society International
  • Workshop: Impact of policymaking in animal-free research – Submitted by: Anke Sikkema, Ministry of agriculture, nature and food quality
  • Round Table: Rigor, Relevance and Reproducibility in (animal) research: when “Science’s 3Rs” come into play – Submitted by: Nicolas Dudoignon, SANOFI R&D
  • Workshop: 3Rs education and training strategies at different educational levels – Submitted by: Chantra Eskes, 3RCC
  • Symposium: Training the Next Generation: The Importance of Harmonized Three Rs Education in Schools and Universities. – Submitted by: Elisabeth Ormandy, Animals in Science Policy Institute
  • Symposium: Education and training – Submitted by: Luisa Bastos, Eurogroup for Animals
  • Other: Alternatives Exhibition (education and training) – Submitted by: Nick Jukes, InterNICHE
  • Key Lectures: Myths and realities for alternatives in education and training – Submitted by: Nick Jukes, InterNICHE
  • Workshop: The State of Animal Use in Higher Education around the World – Submitted by: Ryan Merkley, Physicians Committee for Responsible Medicine
  • Round Table: REplace -EDUCATION – Submitted by: Francesca Caloni, Università degli Studi di Milano
  • Symposium: Implementing the 3Rs in Safety Assessment and Drug Development – Submitted by: Donna W Lee, Genentech


  • Workshop: The Scientific Validity of Replacements for Animal-Derived Antibodies – the next steps OR The Recombinant Replacement Revolution – The 3Rs of antibody development – Submitted by: Alison Gray, AFABILITY / University of Nottingham, UK
  • Symposium: Modeling the muskuloskeletal system and related disorders in vitro – Cells, scaffolds and biomechanics – Submitted by: Annemarie Lang, Charité-Universitätsmedizin Berlin
  • Symposium: Reproducibility in preclinical studies – Submitted by: Kirsty Reid, EFPIA
  • Symposium: Biomed 2.0 -Non-animal Models for Biomedical Research – Submitted by: Laura Gribaldo, EURL-ECVAM,F3 Unit,JRC,EC
  • Symposium: The role of clinical research on the understanding and treatment of diseases – Submitted by: Luisa Bastos, Eurogroup for Animals
  • Dynamic session: Remove ATT, TABST & LABST. How far away we are to global harmonization for those safety tests? – Submitted by: Laura Viviani, Humane Society International
  • Symposium: NASH, the liver disease of the 21st century? Alternative technology in the spotlights. – Submitted by: Vera Rogiers, Innovation Centre-3Rs (IC-3Rs)
  • Workshop: Application of new-approach methodologies to assess the safety of medical devices – Submitted by: Sebastian Hoffmann, seh consulting + services
  • Symposium: Reverse Translation: Maximizing clinical relevance while reducing the need for preclinical data – Submitted by: Jiri Aubrecht, Takeda
  • Workshop: Biomarker-based in vitro tools targeting early Alzheimer’s in a human relevant fashion – Submitted by: Erwin L Roggen, ToxGenSolutions BV
  • Symposium: Pharmaceutical Industry initiatives driving the 3Rs – Submitted by: Kirsty Reid, EFPIA
  • Symposium: 3Rs in vaccines – Submitted by: Denis Lambrigts, GSK
  • Symposium: 3Rs in vaccines batch release – Submitted by: Denis Lambrigts, GSK
  • Workshop: Beyond the 3Rs: Expanding the Use of Human-Relevant Replacement Methods in Biomedical Research – Submitted by: Kathrin Herrmann, Johns Hopkins Bloomberg School of Public Health
  • Workshop: Of mice and men and predictive biology: what would it take to ingrain the 3Rs in biomedical research? – Submitted by: Charu Chandrasekera, Canadian Centre for Alternatives to Animal Methods

Awards and Bursaries

Click here to read more about the ESTIV best poster award and travel grants.

Satellite symposium

Are you planning on organizing a satellite symposium prior to the 11th World Congress on Alternatives and Animal Use in the Life Sciences? WC11 and Klinkhamer Group | conferences & events may offer you help with the organizational tasks and additional communication via WC11. Please contact Klinkhamer Group | conferences & events via email with your proposal for the satellite symposium or for more information.